 The plasma concentration time data for CTP-499 and its metabolites will be analyzed using noncompartmental methods. Actual dosing and sampling times will be used for analysis. The primary pharmacokinetics parameters are: Cmax, Tmax, T12, AUClast and AUCinf for plasma; relative bioavailability; and Ae and CLr for urine. 